Hanmi Pharm. Co., Ltd. Hanmi Pharm. Co., Ltd.

Hanmi Pharm. Co., Ltd.

128940

Rank in Stocks #4356
A globally active pharmaceutical company, Hanmi Pharm. Co., Ltd. was... A globally active pharmaceutical company, Hanmi Pharm. Co., Ltd. was established in Seoul, South Korea, in 1973. The firm concentrates its efforts on researching and developing medical therapies for a range of health issues, including diabetes, obesity, cancer, autoimmune disorders, and various rare diseases.
Share Price
$279.16
Market Cap
$3.54B
Change (1 day)
-2.37%
Change (1 year)
14.50%
Country
KR
Trade Hanmi Pharm. Co., Ltd. (128940)

Category

Healthcare
Operating Margin for Hanmi Pharm. Co., Ltd. (128940)
Operating Margin as of October 2026 TTM: 16.86%
According to Hanmi Pharm. Co., Ltd. latest financial reports and stock price the company's current Operating Margin (TTM) is 16.86%. At the end of 2024 the company had an Operating Margin of 14.46%.
Operating Margin history for Hanmi Pharm. Co., Ltd. from 2010 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
2026 (TTM) 16.86% 16.52%
2025 14.47% 0.07%
2024 14.46% -4.11%
2023 15.08% 27.04%
2022 11.87% 13.92%
2021 10.42% 129.01%
2020 4.55% -51.23%
2019 9.33% 13.37%
2018 8.23% -8.15%
2017 8.96% 195.71%
2016 3.03% -81.16%
2015 16.08% 254.97%
2014 4.53% -46.58%
2013 8.48% 18.77%
2012 7.14% 90.91%
2011 3.74% -430.97%
2010 -1.13% 0.00%
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
19.41% -98.85%
DE
19.68% -98.83%
DE
10.52% -99.38%
JP
17.08% -98.99%
CH
22.93% -98.64%
IN
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.